Race Appoints George Clinical for Phase 1 Trial of RC220
Released
Latest announcements
Announcement summary
Race Appoints George Clinical for Phase 1 Trial of RC220
We invite investors to post their questions, comments and feedback on the 'ask a question' section on this page.
Ask a question
Your question will be sent privately to Racura Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Racura Oncology a question about this announcement.